5.16
price down icon8.35%   -0.47
after-market Handel nachbörslich: 5.35 0.19 +3.68%
loading
Schlusskurs vom Vortag:
$5.63
Offen:
$5.63
24-Stunden-Volumen:
1.34M
Relative Volume:
1.49
Marktkapitalisierung:
$141.49M
Einnahmen:
$160.43M
Nettoeinkommen (Verlust:
$-227.64M
KGV:
-0.075
EPS:
-68.77
Netto-Cashflow:
$-170.79M
1W Leistung:
+61.25%
1M Leistung:
+66.99%
6M Leistung:
+64.33%
1J Leistung:
-70.63%
1-Tages-Spanne:
Value
$5.06
$5.73
1-Wochen-Bereich:
Value
$3.00
$6.20
52-Wochen-Spanne:
Value
$1.38
$18.74

Agenus Inc Stock (AGEN) Company Profile

Name
Firmenname
Agenus Inc
Name
Telefon
781-674-4410
Name
Adresse
3 FORBES ROAD, LEXINGTON, MA
Name
Mitarbeiter
316
Name
Twitter
@Agenus_Bio
Name
Nächster Verdiensttermin
2024-12-05
Name
Neueste SEC-Einreichungen
Name
AGEN's Discussions on Twitter

Vergleichen Sie AGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AGEN
Agenus Inc
5.16 87.73M 160.43M -227.64M -170.79M -68.77
Biotechnology icon
ONC
Beone Medicines Ltd Adr
257.00 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.82 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.282 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
85.54 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
483.07 65.36B 14.09B 4.50B 2.96B 39.28

Agenus Inc Stock (AGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-04 Hochstufung H.C. Wainwright Neutral → Buy
2024-07-19 Herabstufung Robert W. Baird Outperform → Neutral
2024-07-18 Herabstufung H.C. Wainwright Buy → Neutral
2024-07-18 Herabstufung William Blair Outperform → Mkt Perform
2023-06-06 Eingeleitet Robert W. Baird Outperform
2023-02-28 Fortgesetzt H.C. Wainwright Buy
2022-09-28 Eingeleitet SMBC Nikko Outperform
2021-12-16 Eingeleitet H.C. Wainwright Buy
2019-11-19 Fortgesetzt B. Riley FBR Buy
2019-04-22 Eingeleitet B. Riley FBR Buy
2016-10-28 Herabstufung H.C. Wainwright Buy → Neutral
2016-10-27 Bestätigt Maxim Group Buy
2016-03-11 Hochstufung Maxim Group Hold → Buy
2015-12-16 Eingeleitet Jefferies Buy
2015-10-27 Herabstufung Maxim Group Buy → Hold
2015-07-27 Bestätigt MLV & Co Buy
2015-06-11 Eingeleitet Oppenheimer Outperform
2015-01-12 Bestätigt Maxim Group Buy
2015-01-09 Bestätigt MLV & Co Buy
2015-01-09 Bestätigt Maxim Group Buy
2014-12-19 Bestätigt Maxim Group Buy
2014-05-08 Bestätigt Maxim Group Buy
2014-03-14 Bestätigt MLV & Co Buy
2013-10-08 Bestätigt Maxim Group Buy
2012-01-05 Eingeleitet William Blair Outperform
2011-12-01 Eingeleitet Global Hunter Securities Buy
Alle ansehen

Agenus Inc Aktie (AGEN) Neueste Nachrichten

pulisher
Jun 05, 2025

Zydus enters global biologics CDMO market with $75m facility acquisitions - BioProcess International

Jun 05, 2025
pulisher
Jun 05, 2025

Baird Lifts Agenus (AGEN) PT to $6, Maintains Neutral Rating - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Agenus (NASDAQ:AGEN) Upgraded to “Buy” at HC Wainwright - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Agenus (NASDAQ:AGEN) Price Target Raised to $6.00 at Robert W. Baird - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

H.C. Wainwright Upgrades Agenus (AGEN) Stock to Buy - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Zydus Lifesciences to acquire India, Sri Lanka rights for Agenus cancer immunotherapy BOT/BAL - Medical Dialogues

Jun 05, 2025
pulisher
Jun 05, 2025

Agenus and Zydus Lifesciences Enter $141M Strategic Collaboration to Advance BOT/BAL, Expand Zydus’ Biologics Manufacturing in the US - 뉴스와이어

Jun 05, 2025
pulisher
Jun 04, 2025

Agenus Announces Strategic Collaboration with Zydus - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus climbs on deal with India’s Zydus for cancer therapy BOT/BAL - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus IncSigns Partnership Agreements With Zydus Lifesciences - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus Life To Buy Agenus' US Facilities For $75 Million For Entry In Biologics CDMO - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Analyst Upgrades Agenus As Zydus Deal Alleviates Cash OverhangAgenus (NASDAQ:AGEN) - Benzinga

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus Shares Rise After Upgrade From HC Wainwright - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

H.C. Wainwright upgrades Agenus stock on strategic collaboration By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Wall Street Analysts Believe Agenus (AGEN) Could Rally 26.6%: Here's is How to Trade - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus (AGEN) Price Target Raised by Baird as Neutral Rating Mai - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

HC Wainwright & Co. Upgrades Agenus (AGEN) - Nasdaq

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus (AGEN) Upgraded to 'Buy' by HC Wainwright & Co. | AGEN Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus (AGEN) Stock Price Target Increased by Baird | AGEN Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus and Zydus sign agreements for botensilimab and balstilimab - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus gets rights for next gen I-O platforms from Agenus - The Pharma Letter

Jun 04, 2025
pulisher
Jun 04, 2025

HC Wainwright Upgrades Agenus to Buy From Neutral, $25 Price Target - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

H.C. Wainwright upgrades Agenus stock on strategic collaboration - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus (AGEN) Boosted to Buy Following Key Zydus Partnership | A - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus, Agenus team up for next-gen cancer immunotherapies - Healthcare Radius

Jun 04, 2025
pulisher
Jun 04, 2025

Jane Street Group LLC Raises Stock Position in Agenus Inc. (NASDAQ:AGEN) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus to acquire Agenus’ US manufacturing facilities, forays into global biologics CDMO business - Indian Pharma Post

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus Lifesciences acquires Agenus Biologics facilities in US, enters global CDMO market - Express Pharma

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus to enter global biologics CDMO business: Plans to acquire Agenus' U.S. manufacturing facilities to accelerate development of innovative therapies - StreetInsider

Jun 04, 2025
pulisher
Jun 04, 2025

Agenus inks $141M deal with Zydus for cancer drugs, facilities By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Zydus acquires Agenus biologics facilities for CDMO expansion By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

Zydus Lifesciences to acquire Agenus’s two biologics units for USD 125M - Medical Buyer

Jun 03, 2025
pulisher
Jun 03, 2025

With plans to acquire US-based genus Inc, Zydus Lifesciences set to enter the global biologics CDMO business - financialexpress.com

Jun 03, 2025
pulisher
Jun 03, 2025

Zydus Lifesciences Subsidiary Zynext to Acquire 5.9% Stake in Agenus for $16 Million - India Infoline

Jun 03, 2025
pulisher
Jun 03, 2025

Zydus enters global biologics CDMO business, plans to acquire Agenus’ U.S. manufacturing facilities to accelerate development of innovative therapies - Equity Bulls

Jun 03, 2025
pulisher
Jun 03, 2025

Zydus announces plan to acquire US manufacturing units of Agenus Inc - The Indian Express

Jun 03, 2025
pulisher
Jun 03, 2025

Agenus Inc. announced that it expects to receive $15.75 million in funding from Zydus Lifesciences Limited - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Zydus to acquire US biotech firm Agenus’ facilities in California - The Economic Times

Jun 03, 2025
pulisher
Jun 03, 2025

Agenus Stock Is Trading Higher Tuesday: What's Going On? - Benzinga

Jun 03, 2025
pulisher
Jun 03, 2025

Zydus to acquire 2 biologics manufacturing units in U.S. from Agenus for $125 million - The Hindu

Jun 03, 2025
pulisher
Jun 03, 2025

Agenus to Sell US Manufacturing Facilities to Zydus Lifesciences - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Zynext Ventures acquires stake in Agenus, expands its immuno-oncology pipeline and global reach - The Malaysian Reserve

Jun 03, 2025
pulisher
Jun 03, 2025

Zydus buys Agenus' biologics plants in US for $125 mn, licenses cancer therapy | Company Business News - Mint

Jun 03, 2025
pulisher
Jun 03, 2025

Zydus bolsters global biologics play with Agenus acquisition, immuno-oncology licensing pact - Fortune India

Jun 03, 2025
pulisher
Jun 03, 2025

Zydus inks pact to acquire stake in US firm to enter contract manufacturing space - theweek.in

Jun 03, 2025
pulisher
Jun 03, 2025

Zydus Lifesciences to Enter the Global CDMO Business - Contract Pharma

Jun 03, 2025
pulisher
Jun 03, 2025

Zydus Life To Buy Agenus US Facilities For $75 Million For Entry In Biologics CDMO - NDTV Profit

Jun 03, 2025
pulisher
Jun 03, 2025

Agenus (AGEN) Rises on Zydus Partnership to Boost Cancer Therapy - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Zydus forays into global bilogics CDMO business through acquisition of two facilities of Agenus Inc in the US - BusinessLine

Jun 03, 2025
pulisher
Jun 03, 2025

Zydus acquires Agenus biologics facilities for CDMO expansion - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Zydus signs deal with Agenus for BOT and BAL cancer therapies in India - Business Standard

Jun 03, 2025

Finanzdaten der Agenus Inc-Aktie (AGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.15
price down icon 0.86%
$580.59
price up icon 1.24%
$308.00
price up icon 0.88%
$36.54
price up icon 1.27%
$4.8111
price up icon 1.29%
$483.07
price down icon 0.38%
Kapitalisierung:     |  Volumen (24h):